Download Inside Dental Assisting

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts

Dental degree wikipedia , lookup

Scaling and root planing wikipedia , lookup

Dental hygienist wikipedia , lookup

Sjögren syndrome wikipedia , lookup

Periodontal disease wikipedia , lookup

Oral cancer wikipedia , lookup

Dental emergency wikipedia , lookup

Tooth decay wikipedia , lookup

Special needs dentistry wikipedia , lookup

Remineralisation of teeth wikipedia , lookup

Transcript
that can assist in the appraisal of the health status or risk for a multitude of patients’
health conditions. These tests enable clinicians to identify patients whose genetic
susceptibility to periodontal disease may put them at increased risk. This genetic testing
for the interleukin-1 (IL-1) gene cluster, a significant inflammatory mediator,
complements other periodontal screening procedures and other salivary bacterial DNA
testing that can be performed for specific oral pathogens.
Saliva analysis can also be used as a non-invasive screening tool to identify the type(s) of
oral human papilloma virus (HPV) present in the oral cavity. Studies have identified
several high-risk strains of HPV—especially the variants HPV-16 and HPV-18—as
potential etiologic agents in the development of squamous cell carcinoma of the head and
neck (SCCHN).1,2 This increased knowledge enables the clinician to discuss the potential
risk of SCCHN with the patient and determine the appropriate referral and monitoring
recommendations.
Cytology, the harvesting of disaggregated cells and related microscopic material, may be
used as either a field of view or site-specific assessment tool. A clinician may be able to
obtain a considerable amount of information on the patient’s health status, depending on
the collection method, transport mechanisms used, and tests requested. Cytology may
yield important screening information when the patient has health issues that may
preclude performing a surgical biopsy or other procedures at that time.
Liquid-based cytology of the oral cavity is a relatively new, FDA-approved screening
technique. The procedure involves a minimally invasive collection of transepithelial
mucosa cells and other microbiology with a nylon bristle brush, with minimal or no
discomfort to the patient. The collected material and brush are then placed into a special
liquid preservative/fixative bottled solution for transportation to the laboratory for
processing and evaluation. With liquid cytology, the clinician can request tests for several
generalized oral conditions such as herpes simplex infection and candidiasis.
Liquid-based and conventional transepithelial cytology smears, which are often referred
to as a "brush test" or the OralCDx® (OralScan Laboratories Inc,
www.sopreventable.com) are most commonly used to assess specific areas that have been
detected with other screening methods. The brush test is frequently used on suspicious
leukoplakia or erythroplakia areas, to aid in determining the presence or lack of a
potential dysplastic change.
In this role, cytology is an extremely valuable modality used to evaluate an area of
concern for dysplasia, a potentially malignant condition. Cytology assists in helping to
determine if an immediate invasive full-thickness biopsy procedure should be performed,
or if the area should be closely monitored. Cytology is not a substitute for the traditional,
"gold standard" surgical biopsy technique that removes architecturally intact tissue for
histological evaluation. The only accepted method of diagnosing an oral cancer is a
surgical biopsy with a microscopic examination, performed by an oral pathologist to
evaluate all of the available information.